Beijing Surgerii Robotics Achieves Major Milestone with SHURUI® Robot CE Certification

Revolutionizing Surgery with the SHURUI® Robot

On August 28, 2025, a significant milestone in medical technology was reached when Beijing Surgerii Robotics Company Limited received CE certification for its innovative SHURUI® Single-Port Surgical Robot. This state-of-the-art device employs snake-like instruments, marking a new chapter in the realm of minimally invasive surgeries.

Unique Features of the SHURUI® Robot

The SHURUI® Endoscopic Surgical System is designed for precise control during urological and gynecological laparoscopic surgeries, as well as general and thoracoscopic procedures, catering to both adult and pediatric patients. Notably, it is the first single-port surgical robot approved for pediatric use in Europe, setting a global standard for minimally invasive surgical practices.

Utilizing advanced snake-like instrument technology, the SHURUI® robot enables high-precision operations through a single incision, significantly minimizing surgical trauma and expediting patient recovery. Its intelligent motion control and surgeon-friendly interface facilitate safe, accurate, and intuitive operations, particularly in complex pediatric and adult procedures.

Surgeons can now perform tasks that previously required multiple incisions with just one cut, reducing complications and enhancing recovery time for patients. This advancement signifies a considerable leap forward in surgical techniques, transforming patient outcomes.

Adoption and Expansion

To date, Beijing Surgerii Robotics has collaborated with over 70 hospitals across China and nearly 10 in Europe. The SHURUI® Single-Port Surgical Robot has already been employed in over 2,000 surgeries, facilitating more than 50 pioneering surgical techniques. As part of its commitment to excellence, a European Clinical Excellence Center is being established in partnership with IRCAD, aimed at providing standardized training for surgeons throughout Europe, as well as developing innovative surgical approaches and remote demonstration capabilities for single-port surgery.

Beijing Surgerii Robotics is accelerating its international expansion plans, with a vision to provide hospitals and patients worldwide with safer, more accurate, less invasive, and accessible robotic-assisted single-port surgeries. This endeavor is positioned as a critical step towards the future of minimally invasive surgery.

Conclusion

The CE certification of the SHURUI® Single-Port Surgical Robot is not merely a regulatory achievement; it symbolizes the potential of robotic surgery to transform the surgical landscape. As technology continues to advance, the impact on patient care and surgical outcomes will likely become even more profound, paving the way for a new generation of surgical interventions.